HF
PBYI icon

HRT Financial’s Puma Biotechnology PBYI Stock Holding History

HRT Financial’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,073
Closed -$83K – 5060
2026
Q1 		$83K Buy
+13,073
New +$84.3K ﹤0.01% 3383
2024
Q2 		– Sell
-127,231
Closed -$674K – 2879
2024
Q1 		$674K Buy
+127,231
New +$685K ﹤0.01% 1098
2023
Q1 		– Sell
-30,416
Closed -$128K – 3014
2022
Q4 		$128K Buy
+30,416
New +$105K ﹤0.01% 2028
2022
Q3 		– Sell
-18,035
Closed -$51K – 3314
2022
Q2 		$51K Buy
+18,035
New +$44.8K ﹤0.01% 2507
2022
Q1 		– Sell
-80,077
Closed -$243K – 3662
2021
Q4 		$243K Sell
80,077
-20,034
-20% -$87K ﹤0.01% 2409
2021
Q3 		$701K Buy
100,111
+9,995
+11% +$74.8K ﹤0.01% 1709
2021
Q2 		$827K Buy
90,116
+50,317
+126% +$510K 0.01% 1261
2021
Q1 		$386K Buy
39,799
+4,263
+12% +$47.6K ﹤0.01% 1971
2020
Q4 		$364K Sell
35,536
-14,652
-29% -$148K 0.01% 1187
2020
Q3 		$506K Buy
+50,188
New +$511K 0.01% 869

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's PBYI Position: Q2 2026 in Review

HRT Financial sold out of Puma Biotechnology (PBYI) in Q2 2026, closing a stake of 13,073 shares — an estimated $83K sold.

HRT Financial first reported a position in PBYI in Q3 2020 and held it in 10 quarters. The position peaked at $827K in Q2 2021. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • HRT Financial reported no remaining Puma Biotechnology position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 13,073 Puma Biotechnology shares in Q2 2026, an estimated $83K.
  • HRT Financial first reported a position in Puma Biotechnology in Q3 2020 and held it in 10 quarters.
  • HRT Financial's Puma Biotechnology position peaked at $827K in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.